Last reviewed · How we verify
NCT05458778
Detection of Urinary Human Chorionic Gonadotropin (hCG)
trial testing Daily test with urine by the product in Pregnancy Detection in 200 participants. Status unknown.
31 October 2023
Quick facts
| Lead sponsor | Quanovate Tech Inc. |
|---|---|
| Status | Status unknown |
| Study type | OBSERVATIONAL |
| Enrollment | 200 |
| Start date | 29 June 2022 |
| Primary completion | 31 October 2023 |
| Estimated completion | 31 October 2023 |
| Sites | 1 location across United States |
Drugs / interventions tested
- Daily test with urine by the product
Conditions studied
- Pregnancy Detection — all drugs for Pregnancy Detection →
Sponsor
Quanovate Tech Inc.
Who can join
Adults 18 to 80, female only, with Pregnancy Detection. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The Mira Pregnancy Test is an over-the-counter urine hCG test intended for early detection of pregnancy. The test is indicated for use four days before the expected period. Throughout this study, volunteers with non-medical backgrounds were recruited to test hCG with urine samples using the Mira Pregnancy Test during the not pregnancy cycle or pregnancy cycle. To perform the study, a total number of more than 200 volunteers will be recruited to participate in the study.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT05458778
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other Quanovate Tech Inc. trials
Trials by the same sponsor.
- NCT05936840 — Quantum Menstrual Health Monitoring Study · recruiting
- NCT03908697 — Quantum Natural Family Planning Pilot · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05458778 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Quanovate Tech Inc.
- Last refreshed: 1 May 2023
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05458778.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing